• News
  • Media
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
|Videos|November 5, 2021

The Role of Potassium-Binding Agents in Treating Hyperkalemia

Dr. Cary Boyd-Shiwarski explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Pharmacy Times spoke to Dr. Cary Boyd-Shiwarski about her session at the ASN 2021 conference titled "Mechanisms of Potassium Handling in CKD."

Boyd explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Related Content